Buy & Sell Eos Energy Enterprises Inc (EOSE) – Eos Energy Enterprises Inc Price Today
Aura AI Summary
Key Stats
- $2.27BMarket Cap
- EnergySector
- -31.86%3M Drawdown
- $2.50BEnterprise Value
- -Dividend Yield
- 66% Buy | 34% SellTrading Activity
- 9 daysTypical Hold Time
Eos Energy Enterprises Inc (EOSE) is currently valued at a market capitalization of $2.27B, with an enterprise value of $2.50B. Over the past 52 weeks, Eos Energy Enterprises Inc has traded between a low of $4.01 and a high of $19.19, highlighting its annual price range. Over the past three months, Eos Energy Enterprises Inc has recorded a drawdown of -31.86%, reflecting recent price volatility. On average, investors hold Eos Energy Enterprises Inc for approximately 9 days, indicating typical investor behavior on the platform.
About Eos Energy Enterprises Inc
Eos Energy Enterprises provides long-duration energy storage solutions. Its signature zinc-based batteries are designed for utility-scale applications, helping to stabilize power grids and integrate renewable energy.
Most Recent News
Gilead and Merck halt lung cancer trial but report positive HIV drug Phase 3 results.
Gilead Sciences and Merck have stopped their Phase 3 trial combining Trodelvy and Keytruda for metastatic non-small cell lung cancer after it failed to show statistically significant benefits. However, they announced positive Phase 3 results for a ne...

American Airlines signs largest sustainable aviation fuel deal with Google, boosting stock.
American Airlines has signed the largest sustainable aviation fuel (SAF) certificate agreement with Google, securing 35 million gallons of SAF over three years to reduce nearly 300,000 metric tons of CO₂ emissions. This deal supports American Airline...

Over 29 pharma firms advance 35+ Treg cell therapies, promising new treatments for autoimmune and transplant diseases.
The Treg cell-based therapies pipeline is robust with more than 29 pharmaceutical companies developing over 35 therapies targeting autoimmune diseases, graft-versus-host disease, and transplant rejection. Key players like Orca Bio, Cellenkos, and Que...
